Background and purpose: A higher CHADS 2 score or CHA 2DS 2-VASc score is associated with an increased risk of ischaemic stroke in patients with non-valvular atrial fibrillation (NVAF). However, there are no data regarding early neurological outcomes after stroke according to the risk levels. Methods: In this study, a total of 649 stroke patients with NVAF were enrolled and categorized into three groups: low-risk (CHADS 2 score of 0-1), moderate-risk (CHADS 2 score 2-3), or high-risk group (CHADS 2 score ≥4). CHA 2DS 2-VASc score was divided into four groups including 0-1, 2-3, 4-5, and ≥6. We investigated whether there were differences in initial stroke severity, early neurological outcome, and infarct size according to CHADS 2 score or CHA 2DS 2-VASc score in stroke patients with NVAF. Results: The initial National Institutes of Health Stroke Scale (NIHSS) score was highest in high-risk group [9.5, interquartile range (IQR) 4-18], followed by moderate-risk (8, IQR 2-17) and low-risk group (6, IQR 2-15) (P=0.012). Likewise, initial stroke severity increased in a positive fashion with increasing the CHA 2DS 2-VASc score. During hospitalization, those in the high-risk group or higher CHA 2DS 2-VASc score had less improvement in their NIHSS score. Furthermore, early neurological deterioration (END) developed more frequently as CHADS 2 score or CHA 2DS 2-VASc score increased. Multivariate analysis showed being in the high-risk group was independently associated with END (OR 2.129, 95% CI 1.013-4.477). Conclusions: Our data indicate that patients with NVAF and higher CHADS 2 score or CHA 2DS 2-VASc score are more likely to develop severe stroke and a worse clinical course is expected in these patients after stroke presentation.
All Science Journal Classification (ASJC) codes
- Clinical Neurology